Find Sacubitril Sodium manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

KDMF

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

108RELATED EXCIPIENT COMPANIES

177EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sacubitril sodium, 149690-05-1, Ahu-377 sodium, Sacubitril (sodium), Mop72gep8z, Sodium;4-[[(2s,4r)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate
Molecular Formula
C24H28NNaO5
Molecular Weight
433.5  g/mol
InChI Key
RRTBVEJIZWGATF-JKSHRDEXSA-M
FDA UNII
MOP72GEP8Z

Sacubitril Sodium
1 2D Structure

Sacubitril Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate
2.1.2 InChI
InChI=1S/C24H29NO5.Na/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);/q;+1/p-1/t17-,21+;/m1./s1
2.1.3 InChI Key
RRTBVEJIZWGATF-JKSHRDEXSA-M
2.1.4 Canonical SMILES
CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].[Na+]
2.1.5 Isomeric SMILES
CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].[Na+]
2.2 Other Identifiers
2.2.1 UNII
MOP72GEP8Z
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Sacubitril Sodium

2. 149690-05-1

3. Ahu-377 Sodium

4. Sacubitril (sodium)

5. Mop72gep8z

6. Sodium;4-[[(2s,4r)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate

7. Unii-mop72gep8z

8. Sacubitril Sodium Salt

9. Sacubitril Sodium [mi]

10. Schembl21239956

11. Dtxsid90164362

12. Hy-15407b

13. (1,1'-biphenyl)-4-pentanoic Acid, Gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl-, 4-ethyl Ester, Sodium Salt (1:1), (alphar,gammas)-

14. Cs-0079358

15. A937423

16. Q27284149

17. (1,1'-biphenyl)-4-pentanoic Acid, .gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl-, 4-ethyl Ester, Sodium Salt (1:1), (.alpha.r,.gamma.s)-

18. Sodium 4-(((2s,4r)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 433.5 g/mol
Molecular Formula C24H28NNaO5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count12
Exact Mass433.18651728 g/mol
Monoisotopic Mass433.18651728 g/mol
Topological Polar Surface Area95.5 Ų
Heavy Atom Count31
Formal Charge0
Complexity556
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.

Flag Taiwan
Digital Content Digital Content

SACUBITRIL

NDC Package Code : 52076-6260

Start Marketing Date : 2016-05-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

CCSB Company Banner

02

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL

NDC Package Code : 46708-941

Start Marketing Date : 2025-08-26

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

03

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL

NDC Package Code : 65727-079

Start Marketing Date : 2019-04-15

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL

NDC Package Code : 69766-057

Start Marketing Date : 2018-10-29

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL

NDC Package Code : 72023-0012

Start Marketing Date : 2024-10-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRILAT

NDC Package Code : 72023-0011

Start Marketing Date : 2024-10-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Haleos Labs Limited

Country
PCC
Not Confirmed
arrow

Haleos Labs Limited

Country
arrow
PCC
Not Confirmed

SACUBITRIL

NDC Package Code : 72375-0012

Start Marketing Date : 2024-11-05

End Marketing Date : 2027-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 05, 2024

Dr Reddy Company Banner

01

Lead Product(s) : Sacubitril Sodium,Valsartan

Therapeutic Area : Undisclosed

Highest Development Status : Phase I

Partner/Sponsor/Collaborator : Undisclosed

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 05, 2024

Dr Reddy Company Banner

Details:

Sacubitril is a small molecule drug, which is currently being evaluated in Phase I clinical studies for the treatment of essential hypertension.


Lead Product(s): Sacubitril Sodium,Valsartan,Amlodipine

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 20, 2026

blank

02

PCC
Not Confirmed
PCC
Not Confirmed

Details : Sacubitril is a small molecule drug, which is currently being evaluated in Phase I clinical studies for the treatment of essential hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 20, 2026

blank

Details:

DWJ1445 (sacubitril) is a small molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Sacubitril Sodium,Valsartan,DWC202506

Therapeutic Area: Undisclosed Brand Name: DWJ1445

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 01, 2025

blank

03

PCC
Not Confirmed
PCC
Not Confirmed

Details : DWJ1445 (sacubitril) is a small molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.

Product Name : DWJ1445

Product Type : Miscellaneous

Upfront Cash : Inapplicable

December 01, 2025

blank

Details:

Sacubitril is a neprilysin inhibitor and valsartan is an angiotensin II receptor blocker (ARB), the combination is indicated for the treatment of chronic heart failure and reduced ejection fraction.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Sacubitril-Valsartan-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 19, 2025

blank

04

PCC
Not Confirmed
PCC
Not Confirmed

Details : Sacubitril is a neprilysin inhibitor and valsartan is an angiotensin II receptor blocker (ARB), the combination is indicated for the treatment of chronic heart failure and reduced ejection fraction.

Product Name : Sacubitril-Valsartan-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 19, 2025

blank

Details:

Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 10, 2025

blank

05

Humanis

Turkey
arrow
PCC
Not Confirmed

Humanis

Turkey
arrow
PCC
Not Confirmed

Details : Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 10, 2025

blank

Details:

Entresto-Generic (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Entresto-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 24, 2025

blank

06

Lupin Ltd

India
arrow

Details : Entresto-Generic (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure.

Product Name : Entresto-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 24, 2025

blank

Details:

Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Essential Hypertension.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 16, 2024

blank

07

Chong Kun Dang Pharm

South Korea
arrow
PCC
Not Confirmed

Chong Kun Dang Pharm

South Korea
arrow
PCC
Not Confirmed

Details : Sacubitril is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Essential Hypertension.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 16, 2024

blank

Details:

OnArni (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: OnArni

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 15, 2024

blank

08

PCC
Not Confirmed
PCC
Not Confirmed

Details : OnArni (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.

Product Name : OnArni

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 15, 2024

blank

Details:

Sacubright (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Sacubright

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 04, 2024

blank

09

PCC
Not Confirmed
PCC
Not Confirmed

Details : Sacubright (sacubitril and valsartan) is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.

Product Name : Sacubright

Product Type : Miscellaneous

Upfront Cash : Inapplicable

October 04, 2024

blank

Details:

Sacubitril and valsartan is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.


Lead Product(s): Sacubitril Sodium,Valsartan

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Entresto-Generic

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 02, 2024

blank

10

Biocon

India
arrow
PCC
Not Confirmed

Biocon

India
arrow
PCC
Not Confirmed

Details : Sacubitril and valsartan is an oral angiotensin receptor neprilysin inhibitor, which is approved for the treatment of chronic heart failure in 2 years and older patients.

Product Name : Entresto-Generic

Product Type : Miscellaneous

Upfront Cash : Inapplicable

September 02, 2024

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Packaging :

Approval Date : 2025-01-13

Application Number : 213627

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 49MG;51MG

Packaging :

Approval Date : 2025-01-13

Application Number : 213627

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

Regulatory Info : RX

Registration Country : USA

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 97MG;103MG

Packaging :

Approval Date : 2025-01-13

Application Number : 213627

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 49MG;51MG

Packaging :

Approval Date : 12-12-2025

Application Number : 90866

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 24MG;26MG

Packaging :

Approval Date : 11-12-2025

Application Number : 90865

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 97MG;103MG

Packaging :

Approval Date : 12-12-2025

Application Number : 90867

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

07

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : ENTRESTO

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Packaging :

Approval Date : 2015-07-07

Application Number : 207620

Regulatory Info : RX

Registration Country : USA

blank

08

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : ENTRESTO

Dosage Form : TABLET;ORAL

Dosage Strength : 49MG;51MG

Packaging :

Approval Date : 2015-07-07

Application Number : 207620

Regulatory Info : RX

Registration Country : USA

blank

09

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : ENTRESTO

Dosage Form : TABLET;ORAL

Dosage Strength : 97MG;103MG

Packaging :

Approval Date : 2015-07-07

Application Number : 207620

Regulatory Info : RX

Registration Country : USA

blank

10

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Packaging :

Approval Date : 2024-08-22

Application Number : 213604

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

DR REDDYS

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Approval Date : 2025-01-13

Application Number : 213627

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

02

DR REDDYS

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 49MG;51MG

Approval Date : 2025-01-13

Application Number : 213627

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

03

DR REDDYS

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

RLD : No

TE Code : AB

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 97MG;103MG

Approval Date : 2025-01-13

Application Number : 213627

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Dr Reddy Company Banner

04

ALEMBIC

India
PCC
Not Confirmed
arrow

ALEMBIC

India
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 49MG;51MG

Approval Date : 2024-05-28

Application Number : 213682

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

ALEMBIC

India
PCC
Not Confirmed
arrow

ALEMBIC

India
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 97MG;103MG

Approval Date : 2024-05-28

Application Number : 213682

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

ALKEM LABS LTD

India
PCC
Not Confirmed
arrow

ALKEM LABS LTD

India
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Approval Date : 2024-09-16

Application Number : 213764

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

ALKEM LABS LTD

India
PCC
Not Confirmed
arrow

ALKEM LABS LTD

India
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 49MG;51MG

Approval Date : 2024-09-16

Application Number : 213764

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

08

PCC
Not Confirmed
arrow
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Approval Date : 2024-08-30

Application Number : 213680

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

09

LAURUS

India
PCC
Not Confirmed
arrow

LAURUS

India
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 97MG;103MG

Approval Date : 2024-05-28

Application Number : 213676

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

10

CRYSTAL

Country
PCC
Not Confirmed
arrow

CRYSTAL

Country
arrow
PCC
Not Confirmed

SACUBITRIL; VALSARTAN

Brand Name : SACUBITRIL AND VALSARTAN

Dosage Form : TABLET;ORAL

Dosage Strength : 24MG;26MG

Approval Date : 2024-05-28

Application Number : 213605

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 49MG;51MG

Packaging :

Approval Date : 12-12-2025

Application Number : 90866

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 24MG;26MG

Packaging :

Approval Date : 11-12-2025

Application Number : 90865

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTowa International works to research, develop, manufacture, and market, generic and value-added medicines to patients around the world.

Flag Spain
Digital Content Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Valsartan Disodium; Sacubitril Sodium

Brand Name : Sacubitril/Valsartan Pensa

Dosage Form : Film Coated Tablet

Dosage Strength : 97MG;103MG

Packaging :

Approval Date : 12-12-2025

Application Number : 90867

Regulatory Info : Authorized

Registration Country : Spain

Towa Pharmaceutical

04

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacuval™ 24 mg/26 mg

Dosage Form : Film Coated Tablet

Dosage Strength : 24mg; 26mg

Packaging :

Approval Date : 28-10-2024

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

05

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Sacubitril; Valsartan

Brand Name : Sacuval™ 97 mg/103 mg

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 28-10-2024

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

06

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Valsartan; Sacubitril

Brand Name : Entresto

Dosage Form : Film-Coated Tablet

Dosage Strength : 103mg; 97mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

07

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Valsartan; Sacubitril

Brand Name : Neparvis

Dosage Form : Film-Coated Tablet

Dosage Strength : 26mg; 24mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Valsartan; Sacubitril

Brand Name : Entresto

Dosage Form : Film Coated Tablet

Dosage Strength : 97MG; 103 MG

Packaging :

Approval Date : 02-11-2021

Application Number : 151058006IP1

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Valsartan; Sacubitril

Brand Name : Neparvis

Dosage Form : Film Coated Tablet

Dosage Strength : 97MG; 103 MG

Packaging :

Approval Date : 24-06-2016

Application Number : 1161103006

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Sampe
Not Confirmed
arrow
arrow
Sampe
Not Confirmed

Valsartan; Sacubitril

Brand Name : Entresto

Dosage Form : Film Coated Tablet

Dosage Strength : 97MG;103MG

Packaging :

Approval Date : 16-06-2025

Application Number : 151058006IP3

Regulatory Info : Authorized

Registration Country : Spain

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Lubricants & Glidants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Solubilizers

read-more
read-more

Coloring Agents

read-more
read-more

Topical

read-more
read-more

Rheology Modifiers

read-more
read-more

Parenteral

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 149690-05-1 / Sacubitril Sodium API manufacturers, exporters & distributors?

Sacubitril Sodium manufacturers, exporters & distributors 1

48

PharmaCompass offers a list of Sacubitril Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sacubitril Sodium manufacturer or Sacubitril Sodium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sacubitril Sodium manufacturer or Sacubitril Sodium supplier.

API | Excipient name

Sacubitril Sodium

Synonyms

149690-05-1, Ahu-377 sodium, Sacubitril (sodium), Mop72gep8z, Sodium;4-[[(2s,4r)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate, Unii-mop72gep8z

Cas Number

149690-05-1

Unique Ingredient Identifier (UNII)

MOP72GEP8Z

Sacubitril Sodium Manufacturers

A Sacubitril Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sacubitril Sodium, including repackagers and relabelers. The FDA regulates Sacubitril Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sacubitril Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sacubitril Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sacubitril Sodium Suppliers

A Sacubitril Sodium supplier is an individual or a company that provides Sacubitril Sodium active pharmaceutical ingredient (API) or Sacubitril Sodium finished formulations upon request. The Sacubitril Sodium suppliers may include Sacubitril Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Sacubitril Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sacubitril Sodium USDMF

A Sacubitril Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Sacubitril Sodium active pharmaceutical ingredient (API) in detail. Different forms of Sacubitril Sodium DMFs exist exist since differing nations have different regulations, such as Sacubitril Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sacubitril Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Sacubitril Sodium USDMF includes data on Sacubitril Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sacubitril Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sacubitril Sodium suppliers with USDMF on PharmaCompass.

Sacubitril Sodium WC

A Sacubitril Sodium written confirmation (Sacubitril Sodium WC) is an official document issued by a regulatory agency to a Sacubitril Sodium manufacturer, verifying that the manufacturing facility of a Sacubitril Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sacubitril Sodium APIs or Sacubitril Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Sacubitril Sodium WC (written confirmation) as part of the regulatory process.

click here to find a list of Sacubitril Sodium suppliers with Written Confirmation (WC) on PharmaCompass.

Sacubitril Sodium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sacubitril Sodium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sacubitril Sodium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sacubitril Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sacubitril Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sacubitril Sodium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sacubitril Sodium suppliers with NDC on PharmaCompass.

Sacubitril Sodium GMP

Sacubitril Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sacubitril Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sacubitril Sodium GMP manufacturer or Sacubitril Sodium GMP API supplier for your needs.

Sacubitril Sodium CoA

A Sacubitril Sodium CoA (Certificate of Analysis) is a formal document that attests to Sacubitril Sodium's compliance with Sacubitril Sodium specifications and serves as a tool for batch-level quality control.

Sacubitril Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Sacubitril Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sacubitril Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Sacubitril Sodium EP), Sacubitril Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sacubitril Sodium USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty